Evidence map›Paper›PMID 32011892›Full record

ArticleMolecular pharmaceutics2020

Effect of Dopamine D

Anna Schildt, Erik F J de Vries, Antoon T M Willemsen, Bruno Lima Giacobbo, Rodrigo Moraga-Amaro, Jürgen W A Sijbesma, Aren van Waarde, Vesna Sossi, Rudi A J O Dierckx, Janine Doorduin

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular pharmaceutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. No Dopamine Agonist Modulation of Brain [Molecular pharmaceutics · 2022
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Anna SchildtDepartment of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, 9700RB, The Netherlands.ORCID 0000-0001-7587-8318
Erik F J de VriesDepartment of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, 9700RB, The Netherlands.
Antoon T M WillemsenDepartment of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, 9700RB, The Netherlands.
Bruno Lima GiacobboDepartment of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, 9700RB, The Netherlands.
Rodrigo Moraga-AmaroDepartment of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, 9700RB, The Netherlands.
Jürgen W A SijbesmaDepartment of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, 9700RB, The Netherlands.
Aren van WaardeDepartment of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, 9700RB, The Netherlands.
Vesna SossiDepartment of Physics and Astronomy, University of British Columbia, 143-2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.
Rudi A J O DierckxDepartment of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, 9700RB, The Netherlands.
Janine DoorduinDepartment of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, 9700RB, The Netherlands.
University Medical Center Groningen · NLUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interaction of dopaminergic and cholinergic neurotransmission in, e.g., Parkinson's disease has been well established. Here, D

Indexed as

AnimalsCerebellumCorpus StriatumDopamine D2 Receptor AntagonistsFluorine RadioisotopesHaloperidolKineticsMaleParkinson DiseasePiperidinesPositron-Emission TomographyProtein BindingRacloprideRadiopharmaceuticalsRatsRats, WistarDopamine D2 Receptor AntagonistsFluorine Radioisotopesfluoroethoxy-benzovesamicolHaloperidolPiperidinesRacloprideRadiopharmaceuticalsReceptors, sigmaVesicular Acetylcholine Transport Proteinsanimal studiesD2 receptorkinetic modelingParkinson’s diseasepositron emission tomographyvesicular acetylcholine transporterσ receptor

Identifiers

PMID32011892
PMCPMC7054895
OpenAlexW3004768166

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.